Liver bleeding breakthrough? new drug trial aims to save lives
NCT ID NCT07352228
Summary
This study compares two blood pressure medications (carvedilol and propranolol) to see which works better at preventing repeat bleeding in people with advanced liver disease. All 350 participants will first receive a procedure to tie off swollen veins, then take one of the two medications. Researchers will track whether patients experience bleeding again over three years to determine which drug provides better protection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REBLEEDING OF PORTAL HYPERTENSION IN LIVER CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Air Force Medical University
Xi'an, China
Conditions
Explore the condition pages connected to this study.